Cargando…
Role of Ertugliflozin in the Management of Diabetes Mellitus
The novel oral sodium-glucose cotransporter-2 (SGLT2) inhibitor Ertugliflozin (SteglatroTM) is introduced as a monotherapy or in conjunction with another antidiabetic drug regimen for the treatment of type 2 diabetes mellitus (T2DM).Additional safe and efficient treatment options for patients and ph...
Autores principales: | Totade, Manisha, Gaidhane, Shilpa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744393/ https://www.ncbi.nlm.nih.gov/pubmed/36523727 http://dx.doi.org/10.7759/cureus.31404 |
Ejemplares similares
-
The Incidence and Management of Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus
por: Ikoh Rph., Chinyere L, et al.
Publicado: (2023) -
Correlation of FIRE-MADE (Frailty Index in Rural Elderly - Mental Status, Activities of Daily Living, Depression, and Events) With Sarcopenia in Elderly Population of Central Rural India
por: Khan, Khalid I, et al.
Publicado: (2023) -
Managing Diabetes Mellitus With Millets: A New Solution
por: Agrawal, Pragya, et al.
Publicado: (2023) -
Efficacy of Oral Versus Injectable Iron in Patients With Chronic Kidney Disease: A Two-Year Cross-Sectional Study Conducted at a Rural Teaching Hospital
por: Agrawal, Sachin, et al.
Publicado: (2022) -
Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
por: Tahir, Faryal, et al.
Publicado: (2019)